04/06/13. Time to Image

28/02/13. Symposium cannabis and elderly

04/01/13. Last patient included in MS trial!

19/11/12. First patient dosed with Namisol® in a Phase II trial in patients with chronic post-surgical abdominal pain

15/10/12. First patient dosed with Namisol® in a second phase II study in Chronic Pancreatitis

13/09/12. Phase I trial with Namisol® in elderly

02/08/12. Namisol® phase II study commence in pain in dementia

06/10/11. First Chronic Pancreatitis patient dosed with Namisol®

21/09/11. First Alzheimer patient dosed with Namisol®

08/09/11. Echo Pharmaceuticals proud sponsor of the IAMC conference in Bonn

01/09/11. First MS patient dosed with Namisol®

15/04/11. Article in ‘De Ondernemer’

05/07/10. Namisol® granted € 4.5 million

23/01/08. Echo Pharmaceuticals secures funding

07/11/07. Medicinal Cannabis (in Dutch)